anti phospho prb s780 polyclonal (Cell Signaling Technology Inc)
96
Structured Review
Cell Signaling Technology Inc
anti phospho prb s780 polyclonal
Anti Phospho Prb S780 Polyclonal, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 869 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti+phospho-prb+(s780)/Phospho-Rb+(Ser780)+Antibody/pm27214403-470-31-44
Average 96 stars, based on 869 article reviews
Anti Phospho Prb S780 Polyclonal, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 869 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti+phospho-prb+(s780)/Phospho-Rb+(Ser780)+Antibody/pm27214403-470-31-44
Average 96 stars, based on 869 article reviews
anti phospho prb s780 polyclonal - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Incubation:Article Title: The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2. Article Snippet: In brief MEF2C is an essential immune checkpoint that prevents microglial overactivation, though its mechanisms remain elusive.. Hu et al. reveal that MEF2C restrains microglial overactivation via modulating the p21CDK2-RB-NFkB axis.. In Mef2c-deficient mice, the CDK2 inhibitor BMS265246 mitigates microglial overactivation, neuronal loss, and ASD-like behaviors, establishing CDK2 as a promising therapeutic target for neurological disorders associated with microglial overactivation. Article Title: IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα Article Snippet: 20 μg of proteins were separated on BoltTM 4–12% Bis-Tris mini protein gel (Thermo Fisher Scientific) and transferred to PVDF membranes (Immobilon-P membrane, Thermo Fisher Scientific). .. Membranes were incubated for 1 h at room temperature (RT) in blocking solution (4% non-fat dried milk in TBST, Tris-buffered saline solution + 0.5% Tween), then overnight at 4 °C with anti-IRF1, anti-p21 WAF , Western Blot:Article Title: MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment. Article Snippet: Total lysates and chromatin-bound protein prepared from nonconfluent cells were subjected to immunoblot analysis using antiMUC1-C (#MA5–11202, 1:1000 dilution; Thermo Fisher Scientific, Waltham, MA, USA), anti-NaKATPase1 (3010S, 1:1000, Cell Signaling Technology, Danvers, MA, USA), anti-LaminB1 (66095-1-Ig, 1:2000, Proteintech, Rosemont, IL, USA), anti-α-tubulin (2144S, 1:1000, CST), anti-H3 (9715S, 1:1000, CST), anti-ER (8644S, 1:1000, Cell Signaling Technology), anti-β-actin (A5441, 1:10,000 dilution, Sigma-Aldrich), anti-SRC-3 (2126S, 1:1000, CST), anti-pSRC3(S857) (PA5-106189, Thermo Fischer Scientific), anti-MK2 (12155S, 1:1000, CST), antiMED1 (51613S, 1:1000, CST), anti-pMED1(T1457) (ab60950, 1:500, abcam), anti-CDK7 (2916S, 1:1000, CST), anti—pCDK7(T170) (ab155976, 1:1000, abcam), anti-pPol II(pRpb1)(S7) (13780S, 1:500, CST), anti-Pol II(Rpb1) (14958T, 1:1000, CST), anti-pRB(S780) (9307S, 1:1000, CST), anti-RB (9309S, 1:1000, CST) and anti-E2F1 (3742, 1:1000, CST) as described25. .. Total lysates and chromatin-bound protein prepared from nonconfluent cells were subjected to immunoblot analysis using antiMUC1-C (#MA5–11202, 1:1000 dilution; Thermo Fisher Scientific, Waltham, MA, USA), anti-NaKATPase1 (3010S, 1:1000, Cell Signaling Technology, Danvers, MA, USA), anti-LaminB1 (66095-1-Ig, 1:2000, Proteintech, Rosemont, IL, USA), anti-α-tubulin (2144S, 1:1000, CST), anti-H3 (9715S, 1:1000, CST), anti-ER (8644S, 1:1000, Cell Signaling Technology), anti-β-actin (A5441, 1:10,000 dilution, Sigma-Aldrich), anti-SRC-3 (2126S, 1:1000, CST), anti-pSRC3(S857) (PA5-106189, Thermo Fischer Scientific), anti-MK2 (12155S, 1:1000, CST), antiMED1 (51613S, 1:1000, CST), anti-pMED1(T1457) (ab60950, 1:500, abcam), anti-CDK7 (2916S, 1:1000, CST), anti—pCDK7(T170) (ab155976, 1:1000, abcam), anti-pPol II(pRpb1)(S7) (13780S, 1:500, CST), anti-Pol II(Rpb1) (14958T, 1:1000, CST), anti-pRB( Article Title: MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment Article Snippet: .. Total lysates and chromatin-bound protein prepared from non-confluent cells were subjected to immunoblot analysis using anti-MUC1-C (#MA5–11202, 1:1000 dilution; Thermo Fisher Scientific, Waltham, MA, USA), anti-NaKATPase1 (3010S, 1:1000, Cell Signaling Technology, Danvers, MA, USA), anti-LaminB1 (66095-1-Ig, 1:2000, Proteintech, Rosemont, IL, USA), anti-α-tubulin (2144S, 1:1000, CST), anti-H3 (9715S, 1:1000, CST), anti-ER (8644S, 1:1000, Cell Signaling Technology), anti-β-actin (A5441, 1:10,000 dilution, Sigma-Aldrich), anti-SRC-3 (2126S, 1:1000, CST), anti-pSRC3(S857) (PA5-106189, Thermo Fischer Scientific), anti-MK2 (12155S, 1:1000, CST), anti-MED1 (51613S, 1:1000, CST), anti-pMED1(T1457) (ab60950, 1:500, abcam), anti-CDK7 (2916S, 1:1000, CST), anti—pCDK7(T170) (ab155976, 1:1000, abcam), anti-pPol II(pRpb1)(S7) (13780S, 1:500, CST), anti-Pol II(Rpb1) (14958T, 1:1000, CST), anti-pRB( other:Article Title: A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways Article Snippet: The following agents were obtained from commercial sources: vascular endothelial growth factor-A 165 (Merck Millipore, Billerica, MA, USA); anti-phospho-VEGFR-2 (Y1175), anti-phospho-MEK (S217/S221), anti-MEK, anti-phospho-Src (Y416), anti-Src, anti-phospho-p70 S6K (T421/S424), anti-phospho-Akt (S473), anti-phospho-ERK (T202/Y204), anti-phospho-pRb (S780), and CRISPR:Article Title: Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia Article Snippet: .. Target Company Clone # Catalog # RRID # pAKT(T308) Cell Signaling D25E6 13038s AB_2629447 pAKT(S473) Cell Signaling D9E 4060s AB_2315049 pAKT(T450) Cell Signaling polyclonal 9267s AB_823676 AKT Cell Signaling polyclonal 9272s AB_329827 NICD (V1744) Cell Signaling D3B8 4147s AB_2153348 C-MYC Abcam Y69 ab32072 AB_731658 P85 Cell Signaling 19H8 4257 AB_659889 pS6K (T421/S424) Cell Signaling polyclonal 9204s AB_2265913 pS6K (T389) Cell Signaling polyclonal 9205s AB_330944 p70 S6K Cell Signaling polyclonal 9202s AB_331676 pS6 Ribosomal protein (S235/236) Cell Signaling polyclonal 2211s AB_331679 S6 Ribosomal protein Cell Signaling 54D2 2317s AB_2238583 CRISPR-CAS9 Abcam 7A9-3A3 ab191468 AB_2692325 BCL-xL Abcam polyclonal ab98143 AB_10674728 BCL2 Cell Signaling polyclonal 2872T AB_10693462 TATA binding proteinTBP Abcam mAbcam51841 ab51841 AB_945758 p-Tuberin/TSC2 (S939) Cell Signaling polyclonal 3615T AB_2207796 Tuberin/TSC2 Cell Signaling D93F12 4308T AB_10547134 pBAD (S136) Cell Signaling D25H8 4366T AB_10547878 BAD Cell Signaling D24A9 9239T AB_2062127 pRB (S807/811) Cell Signaling Binding Assay:Article Title: Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia Article Snippet: .. Target Company Clone # Catalog # RRID # pAKT(T308) Cell Signaling D25E6 13038s AB_2629447 pAKT(S473) Cell Signaling D9E 4060s AB_2315049 pAKT(T450) Cell Signaling polyclonal 9267s AB_823676 AKT Cell Signaling polyclonal 9272s AB_329827 NICD (V1744) Cell Signaling D3B8 4147s AB_2153348 C-MYC Abcam Y69 ab32072 AB_731658 P85 Cell Signaling 19H8 4257 AB_659889 pS6K (T421/S424) Cell Signaling polyclonal 9204s AB_2265913 pS6K (T389) Cell Signaling polyclonal 9205s AB_330944 p70 S6K Cell Signaling polyclonal 9202s AB_331676 pS6 Ribosomal protein (S235/236) Cell Signaling polyclonal 2211s AB_331679 S6 Ribosomal protein Cell Signaling 54D2 2317s AB_2238583 CRISPR-CAS9 Abcam 7A9-3A3 ab191468 AB_2692325 BCL-xL Abcam polyclonal ab98143 AB_10674728 BCL2 Cell Signaling polyclonal 2872T AB_10693462 TATA binding proteinTBP Abcam mAbcam51841 ab51841 AB_945758 p-Tuberin/TSC2 (S939) Cell Signaling polyclonal 3615T AB_2207796 Tuberin/TSC2 Cell Signaling D93F12 4308T AB_10547134 pBAD (S136) Cell Signaling D25H8 4366T AB_10547878 BAD Cell Signaling D24A9 9239T AB_2062127 pRB (S807/811) Cell Signaling Blocking Assay:Article Title: IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα Article Snippet: 20 μg of proteins were separated on BoltTM 4–12% Bis-Tris mini protein gel (Thermo Fisher Scientific) and transferred to PVDF membranes (Immobilon-P membrane, Thermo Fisher Scientific). .. Membranes were incubated for 1 h at room temperature (RT) in blocking solution (4% non-fat dried milk in TBST, Tris-buffered saline solution + 0.5% Tween), then overnight at 4 °C with anti-IRF1, anti-p21 WAF , Saline:Article Title: IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα Article Snippet: 20 μg of proteins were separated on BoltTM 4–12% Bis-Tris mini protein gel (Thermo Fisher Scientific) and transferred to PVDF membranes (Immobilon-P membrane, Thermo Fisher Scientific). .. Membranes were incubated for 1 h at room temperature (RT) in blocking solution (4% non-fat dried milk in TBST, Tris-buffered saline solution + 0.5% Tween), then overnight at 4 °C with anti-IRF1, anti-p21 WAF , |